Lenalidomide/Revlimid - Brand Name or Equal

The Department of Veterans Affairs is seeking a vendor to provide Lenalidomide/Revlimid medication, brand name or equal, for the Edward Hines Jr. VA Hospital Pharmacy Service. The contract will be for a period of one year, from January 5, 2026, to January 4, 2027. The vendor must be certified with the Lenalidomide Risk Evaluation and Mitigation Strategy (REMS) program and must be able to dispense the medication to patients who are enrolled and meet the conditions of the program. The vendor will be responsible for shipping the medication to the VA hospital or directly to patients. • The vendor must be able to provide the medication in various strengths, including 2.5mg, 5mg, 10mg, 15mg, 20mg, and 25mg oral capsules. • The vendor must be able to provide clinical support from a pharmacist and financial assistance coordination. • The vendor must be able to provide ongoing adherence support and exceptional patient care and caregiver support. • The vendor must be able to ship the medication via a trackable method and provide delivery confirmation. • The vendor must be able to provide electronic invoicing through the Tungsten Network.